- Home
- CNF vs HLN Comparison
CNF vs HLN Comparison
Compare CNF & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNF
- HLN
- Stock Information
- Founded
- CNF 1999
- HLN 2022
- Country
- CNF China
- HLN United Kingdom
- Employees
- CNF N/A
- HLN N/A
- Industry
- CNF Finance: Consumer Services
- HLN Package Goods/Cosmetics
- Sector
- CNF Finance
- HLN Consumer Discretionary
- Exchange
- CNF Nasdaq
- HLN Nasdaq
- Market Cap
- CNF 35.7M
- HLN 48.2B
- IPO Year
- CNF 2018
- HLN N/A
- Fundamental
- Price
- CNF $0.76
- HLN $9.60
- Analyst Decision
- CNF
- HLN Buy
- Analyst Count
- CNF 0
- HLN 1
- Target Price
- CNF N/A
- HLN $10.95
- AVG Volume (30 Days)
- CNF 175.7K
- HLN 12.8M
- Earning Date
- CNF 08-27-2025
- HLN 07-31-2025
- Dividend Yield
- CNF N/A
- HLN 1.85%
- EPS Growth
- CNF N/A
- HLN 38.94
- EPS
- CNF 0.08
- HLN 0.20
- Revenue
- CNF $85,661,735.00
- HLN $14,062,871,660.00
- Revenue This Year
- CNF $252.34
- HLN $3.63
- Revenue Next Year
- CNF N/A
- HLN $4.37
- P/E Ratio
- CNF $10.47
- HLN $23.95
- Revenue Growth
- CNF N/A
- HLN N/A
- 52 Week Low
- CNF $0.37
- HLN $8.80
- 52 Week High
- CNF $2.84
- HLN $11.42
- Technical
- Relative Strength Index (RSI)
- CNF 61.85
- HLN 19.49
- Support Level
- CNF $0.72
- HLN $9.54
- Resistance Level
- CNF $0.81
- HLN $10.15
- Average True Range (ATR)
- CNF 0.08
- HLN 0.11
- MACD
- CNF 0.00
- HLN -0.05
- Stochastic Oscillator
- CNF 80.60
- HLN 6.18
About CNF CNFinance Holdings Limited each representing twenty (20)
CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, it has an operation in PRC.
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.